We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Transplantation of PSC-derived myogenic progenitors counteracts disease phenotypes in FSHD mice.
- Authors
Azzag, Karim; Bosnakovski, Darko; Tungtur, Sudheer; Salama, Peter; Kyba, Michael; Perlingeiro, Rita C. R.
- Abstract
Facioscapulohumeral muscular dystrophy (FSHD) is a genetically dominant progressive myopathy caused by improper silencing of the DUX4 gene, leading to fibrosis, muscle atrophy, and fatty replacement. Approaches focused on muscle regeneration through the delivery of stem cells represent an attractive therapeutic option for muscular dystrophies. To investigate the potential for cell transplantation in FSHD, we have used the doxycycline-regulated iDUX4pA-HSA mouse model in which low-level DUX4 can be induced in skeletal muscle. We find that mouse pluripotent stem cell (PSC)-derived myogenic progenitors engraft in muscle actively undergoing DUX4-mediated degeneration. Donor-derived muscle tissue displayed reduced fibrosis and importantly, engrafted muscles showed improved contractile specific force compared to non-transplanted controls. These data demonstrate the feasibility of replacement of diseased muscle with PSC-derived myogenic progenitors in a mouse model for FSHD, and highlight the potential for the clinical benefit of such a cell therapy approach.
- Subjects
FACIOSCAPULOHUMERAL muscular dystrophy; PLURIPOTENT stem cells; MUSCULAR dystrophy; MUSCULAR atrophy; CELL transplantation; NEMALINE myopathy; GENE silencing
- Publication
NPJ Regenerative Medicine, 2022, Vol 7, Issue 1, p1
- ISSN
2057-3995
- Publication type
Article
- DOI
10.1038/s41536-022-00249-0